Provided by Tiger Trade Technology Pte. Ltd.

Pacific Biosciences of California

2.72
+0.02000.74%
Post-market: 2.70-0.0201-0.74%17:55 EDT
Volume:20.30M
Turnover:53.84M
Market Cap:844.52M
PE:-6.31
High:2.74
Open:2.62
Low:2.50
Close:2.70
52wk High:3.44
52wk Low:1.07
Shares:310.49M
Float Shares:302.00M
Volume Ratio:0.47
T/O Rate:6.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4310
EPS(LYR):-1.8215
ROE:-929.32%
ROA:-14.07%
PB:-25.43
PE(LYR):-1.49

Loading ...

Barclays Sticks to Their Sell Rating for Pacific Biosciences (PACB)

TIPRANKS
·
Yesterday

PacBio, TychoBio collaborate to generate full-length RNA data

TIPRANKS
·
Oct 06

Pacbio and Tychobio Collaborate to Train AI Models for Rare Disease Rna Therapeutics

THOMSON REUTERS
·
Oct 06

PacBio Partners with TychoBio to Generate Long-Read RNA Data for AI-Designed Rare Disease Therapies

Reuters
·
Oct 06

NASD Most Active Issues

Dow Jones
·
Oct 01

Pacific Biosciences up over 30%, on Pace for Largest Percent Increase Since July 2024

Dow Jones
·
Oct 01

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Sep 11

PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference

GlobeNewswire
·
Sep 04

PacBio Releases Transcript of 2Q26 Earnings Call

Reuters
·
Aug 07

10x Genomics Q2 Revenue Rises on Atera Demand

Reuters
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)

TIPRANKS
·
Aug 06

PacBio CEO Christian Henry steps down, Mark Van Oene succeeds

TIPRANKS
·
Aug 06

Pacific Biosciences of California, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Pacific Biosciences of California Appoints New CEO, Plans to Cut 8% of Workforce

Dow Jones
·
Aug 06

Pacific Biosciences of California - Expects $30 Mln-$40 Mln Annualized Operating Expense Reduction by End of 2027 - SEC Filing

THOMSON REUTERS
·
Aug 06

Pacific Biosciences of California - Restructuring to Reduce Workforce by About 8% - SEC Filing

THOMSON REUTERS
·
Aug 06

PacBio Q2 2026 Earnings: Consumables Growth Could Not Prevent Margin Compression

TradingKey
·
Aug 06

Pacific Biosciences Q2 Adj. Loss Bigger than Estimates on Margin Pressure

Reuters
·
Aug 06

Pacific Biosciences Q2 Adj. EPS $(0.14) Misses $(0.13) Estimate, Sales $39.007M Miss $40.067M Estimate

Benzinga Earnings
·
Aug 06

Pacific Biosciences of California - Christian Henry Steps Down as President and CEO

THOMSON REUTERS
·
Aug 06